A Patient Blood Management Program in Prosthetic Joint Arthroplasty Decreases Blood Use and Improves Outcomes


      The objective of this study was to determine if a Patient Blood Management (PBM) program implemented for patients undergoing THA or TKA would result in a decrease in the percentage of patients transfused PRBCs and improve outcomes. Decision support, a key driver for this program, was built into the electronic medical record. This retrospective cohort study included 12,590 patients and demonstrated a 44% decrease in the percentage of patients transfused. This was associated with a significant reduction in complications, 30 day readmissions and HLOS. A PBM program for patients undergoing prosthetic joint arthroplasty for primary and revision total hip and knee arthroplasty results in fewer transfusions and is associated with improved outcomes.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The Journal of Arthroplasty
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • U.S. Department of Health and Human Services
        The 2011 national blood collection and utilization survey report.
        U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, Washington, DC2011: 3
        • Bracey A.W.
        • Radovancevic R.
        • Riggs S.A.
        • et al.
        Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome.
        Transfusion. 1999; 39: 1070
        • Salpeter S.R.
        • Buckley J.S.
        • Chatterjee S.
        Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review.
        Am J Med. 2014; 127: 124
        • Hébert P.C.
        • Wells G.
        • Blajchman M.A.
        • et al.
        A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.
        N Engl J Med. 1999; 340: 409
        • Carson J.L.
        • Terrin M.L.
        • Noveck H.
        • et al.
        Liberal or restrictive transfusion in high-risk patients after hip surgery.
        N Engl J Med. 2011; 365: 2453
        • Bern M.M.
        • Bierbaum B.E.
        • Katz J.N.
        • et al.
        Autologous blood donation and subsequent blood use in patients undergoing total knee arthroplasty.
        Transfus Med. 2006; 16: 313
        • Billote D.B.
        • Glisson S.N.
        • Green D.
        • et al.
        A prospective, randomized study of preoperative autologous donation for hip replacement surgery.
        JBJS. 2002; 84-A: 1299
        • Burdick T.
        • Elco J.
        • Sexton L.
        Achieving a shared baseline: implementing evidence based clinical practices.
        Presented at the 20th Annual Society for Health Systems Conference at the Rosen Plaza Hotel in Orlando, FL. 2008
        • Shander A.
        • Hofmann A.
        • Ozawa S.
        • et al.
        Activity-based costs of blood transfusions in surgical patients at four hospitals.
        Transfusion. 2010; 50 ([Epub 2009 Dec 9]): 753
        • Rohde J.M.
        • Dimcheff D.E.
        • Blumberg N.
        • et al.
        Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis.
        JAMA. 2014; 311: 1317
        • Vuille-Lessard E.
        • Boudreault D.
        • Girard F.
        • et al.
        Red blood cell transfusion practice in elective orthopedic surgery: a multicenter cohort study.
        Transfusion. 2010; 50 ([Epub 2010 Oct 4]): 2117
        • Loftus T.
        • Agee C.
        • Jaffe R.
        • et al.
        A simplified pathway for total knee arthroplasty improves outcomes.
        J Knee Surg. 2014; 27 ([Epub 2013 Nov 14]): 221
        • Wei Z.
        • Liu M.
        The effectiveness and safety of tranexamic acid in total hip or knee arthroplasty: a meta-analysis of 2720 cases.
        Transfus Med. 2015; ([Epub ahead of print])
        • Carling M.S.
        • Jeppsson A.
        • Eriksson B.I.
        • et al.
        Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study.
        J Orthop Surg Res. 2015; 10: 48
        • Boral L.I.
        • Bernard A.
        • Hjorth T.
        • et al.
        How do I implement a more restrictive transfusion trigger of hemoglobin level of 7 g/dL at my hospital?.
        Transfusion. 2015; ([Epub ahead of print])